IBT
PRQR icon

International Biotechnology Trust’s ProQR Therapeutics PRQR Stock Holding History

International Biotechnology Trust’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-56,000
Closed -$511K – 62
2019
Q2 		$511K Buy
+56,000
New +$661K 0.19% 61

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

International Biotechnology Trust's PRQR Position: Q3 2019 in Review

International Biotechnology Trust sold out of ProQR Therapeutics (PRQR) in Q3 2019, closing a stake of 56,000 shares — an estimated $511K sold.

International Biotechnology Trust first reported a position in PRQR in Q2 2019 and held it in 1 quarter. The position peaked at $511K in Q2 2019. 50 funds tracked by Wall St. Rank hold PRQR as of Q3 2019.

  • International Biotechnology Trust reported no remaining ProQR Therapeutics position as of Q3 2019 after selling out during the quarter.
  • International Biotechnology Trust sold 56,000 ProQR Therapeutics shares in Q3 2019, an estimated $511K.
  • International Biotechnology Trust first reported a position in ProQR Therapeutics in Q2 2019 and held it in 1 quarter.
  • International Biotechnology Trust's ProQR Therapeutics position peaked at $511K in Q2 2019.
  • 50 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2019.

Based on International Biotechnology Trust's 13F filing for Q3 2019, filed 14 Nov 2019.